Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

May 24, PharmAust Clinical Trials Update

PharmAust Clinical Trials Update

Category: News & Announcements 2022By PharmAust May 24, 2022

Related posts

July 1, Top 20 Shareholders
July 1, 2022

June 1, Top 20 Shareholders
June 1, 2022

May 30, Fiona Milner appointed Epichem General Manager
May 30, 2022

May 27, Resignation of Dr Richard Mollard
May 27, 2022

May 17, PharmAust receives $210k prepayment of forecast R&D rebate
May 17, 2022

May 16, MPL tablets arrive in Melbourne for MND Clinical Trial
May 16, 2022

Recent Articles

July 1, Top 20 Shareholders
July 1, 2022
June 1, Top 20 Shareholders
June 1, 2022
May 30, Fiona Milner appointed Epichem General Manager
May 30, 2022
May 27, Resignation of Dr Richard Mollard
May 27, 2022

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

Retweet on Twitter PharmAust Retweeted

Epichem @epichem·

𝐖𝐄𝐋𝐂𝐎𝐌𝐄 Fiona Milner!

Today we are rolling out the red carpet as Fiona Milner joins Epichem Pty Ltd as General Manager. The Epichem team are thrilled to have Fiona on board and we look forward to working with her.

#teamepichem

Reply on Twitter 1541992242344333312 Retweet on Twitter 15419922423443333121 Like on Twitter 15419922423443333125 Twitter 1541992242344333312

Copyright © 2020 Pharmaust. All rights reserved.

nil

Website Design & Digital Marketing Perth by Total Click Solutions